Biology of myasthenia gravis.
D000109:Acetylcholine / Q000502:physiology; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000503:physiopathology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy; D010956:Plasmapheresis; D011950:Receptors, Cholinergic / Q000502:physiology; D013934:Thymectomy
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D002800:Cholinesterase Inhibitors; D011950:Receptors, Cholinergic; D000109:Acetylcholine